RussellDCohenMDAGAF, FACG
Gastroenterology • Chicago, ILInflammatory Bowel Disease
Professor of Medicine, University of Chicago Medicine
Dr. Cohen is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
5841 S. MARYLAND
M/C 4076
Chicago, IL 60637Phone+1 773-702-1675Fax+1 773-702-2182- Is this information wrong?
Education & Training
University of ChicagoFellowship, Gastroenterology, 1993 - 1996
Beth Israel Deaconess Medical CenterResidency, Internal Medicine, 1990 - 1993
Icahn School of Medicine at Mount SinaiClass of 1990- University of Chicago Medical CenterFellowship, Health Studies
University of ChicagoFellowship, Inflammatory Bowel Disease
Cornell UniversityBS, Biological Sciences
Certifications & Licensure
IL State Medical License 1993 - 2026
IN State Medical License 2023 - 2025- American Board of Internal Medicine Gastroenterology
Awards, Honors, & Recognition
- Fellows (FACG) The American College of Gastroenterology, 2004
- Regional Top Doctor Castle Connolly, 2014
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
- Join now to see all
Clinical Trials
- Efficacy and Safety of Anti-MAP Therapy in Adult Crohn's Disease Start of enrollment: 2013 Sep 01
- Study to Determine Risk Factors for Post-operative Infection in Inflammatory Bowel Disease Start of enrollment: 2014 Feb 01
Publications & Presentations
PubMed
- 1 citationsReal World Clinical Effectiveness and Safety of Ozanimod in the Treatment of Ulcerative Colitis: 1-Year Follow-Up from a Tertiary Center.Choi, D., Garcia, N., Choi, N., Picker, E., Cohen, N., Krugliak Cleveland, N., Cohen, R., Dalal, S., Pekow, J., Rubin, D.> ;Digestive Diseases and Sciences. 2024 Feb 1
- Risankizumab Effectiveness and Safety in Crohn's Disease: Real-world Data From a Large Tertiary Center.Choi, D., Choi, N., Zinger, A., Cohen, R., Rubin, D.> ;Clinical Gastroenterology and Hepatology. 2023 Dec 7
- Looking from the Past to the Future: How Janus Kinase Inhibitors Have Altered the Therapy of Ulcerative Colitis.Tenzin Choden, Russell D Cohen> ;Digestive Diseases and Sciences. 2023 Jun 1
- Join now to see all
Journal Articles
- Correction to: Risk Factors for Clostridium Difficile Isolation in Inflammatory Bowel Disease: A Prospective StudySushila Dalal, Vijaya L Rao, Laura R Glick, Russell Cohen, Ayal Hirsch, Dejan Micic, Joel Pekow, Atsushi Sakuraba, David T Rubin, Digestive Diseases and Sciences
- Pregnancy Outcomes Reported During the 13-Year TREAT Registry: A Descriptive ReportRussell D Cohen, Uma Mahadevan, Bruce A Salzberg, Gary R Lichtenstein, William J Sandborn, Michael Safdi, Nature
Authored Content
- Effectiveness of Ustekinumab Dose Escalation in Crohn's PatientsFebruary 2020
- Assessment of Peri-Polyp Biopsy Specimens of Flat Mucosa in Patients with Inflammatory Bowel DiseaseApril 2018
- Assessment of Peri-Polyp Biopsies of Flat Mucosa in Patients with Inflammatory Bowel DiseaseJanuary 2018
Press Mentions
New Guidelines Recommend Stool and Blood Tests to Monitor Ulcerative ColitisFebruary 24th, 2023- 203 UChicago Medicine Doctors Named to 2022 Top Docs ListJanuary 21st, 2022
VIDEO: Entyvio Post-Marketing Safety Data Consistent with Previous Clinical TrialsDecember 17th, 2018- Join now to see all
Professional Memberships
- Member
- Fellow
Hospital Affiliations
University of Chicago Medical CenterChicago, Illinois
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
